Literature DB >> 17670513

The MARS trial: mesothelioma and radical surgery.

Tom Treasure1, Carol Tan, Loïc Lang-Lazdunski, David Waller.   

Abstract

The increasing incidence of malignant pleural mesothelioma has demanded the attention of thoracic surgeons worldwide. Can radical surgery cure mesothelioma or add usefully to the length and quality of life for its victims? The MARS (mesothelioma and radical surgery) trial is open and recruiting in Britain. If the trial proves feasible we will seek to make an international study.

Entities:  

Year:  2005        PMID： 17670513     DOI： 10.1510/icvts.2005.123430

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN： 1569-9285


  4 in total

Review 1.  Pulmonary metastasectomy: a common practice based on weak evidence.

Authors:  Tom Treasure
Journal:  Ann R Coll Surg Engl       Date:  2007-11       Impact factor: 1.891

2.  A possible association between aprotinin and improved survival after radical surgery for mesothelioma.

Authors:  Peter H Norman; Peter F Thall; Ronaldo V Purugganan; Bernhard J C J Riedel; Dilip R Thakar; David C Rice; Lisa Huynh; Wei Qiao; Sijin Wen; W Roy Smythe
Journal:  Cancer       Date:  2009-02-15       Impact factor: 6.860

3.  Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma.

Authors:  Elizabeth K Sage; Krishna K Kolluri; Katrina McNulty; Sofia Da Silva Lourenco; Tammy L Kalber; Katherine L Ordidge; Derek Davies; Y C Gary Lee; Adam Giangreco; Sam M Janes
Journal:  Thorax       Date:  2014-02-24       Impact factor: 9.139

Review 4.  Malignant mesothelioma.

Authors:  Alastair J Moore; Robert J Parker; John Wiggins
Journal:  Orphanet J Rare Dis       Date:  2008-12-19       Impact factor: 4.123
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.